Skip to main navigation Skip to search Skip to main content

Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis (IPF): A Randomized, Double-Glind, Placebo-Controlled, 52-Week Dose Ranging Study

Project: Research

Project Details

StatusFinished
Effective start/end date10/13/1501/1/18

Funding

  • Sanofi US Services Incorporated: $12,500.00